Table of Contents
Journal of Allergy
Volume 2012, Article ID 316049, 12 pages
http://dx.doi.org/10.1155/2012/316049
Review Article

Mechanisms of Remodeling in Asthmatic Airways

Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA

Received 9 June 2011; Revised 7 September 2011; Accepted 10 October 2011

Academic Editor: Teal S. Hallstrand

Copyright © 2012 Adrian Shifren et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. P. Anderson, “Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease,” The Lancet, vol. 372, no. 9643, pp. 1107–1119, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. M. H. Grol, J. Gerritsen, J. M. Vonk et al., “Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years: a 30-year follow-up study,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 6, pp. 1830–1837, 1999. View at Google Scholar · View at Scopus
  3. P. Lange, J. Parner, J. Vestbo, P. Schnohr, and G. Jensen, “A 15-year follow-up study of ventilatory function in adults with asthma,” New England Journal of Medicine, vol. 339, no. 17, pp. 1194–200, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. W. J. W. Kelly, I. Hudson, J. Raven, P. D. Phelan, M. C. F. Pain, and A. Olinsky, “Childhood asthma and adult lung function,” American Review of Respiratory Disease, vol. 138, no. 1, pp. 26–30, 1988. View at Google Scholar · View at Scopus
  5. R. J. Homer and J. A. Elias, “Airway remodeling in asthma: therapeutic implications of mechanisms,” Physiology, vol. 20, no. 1, pp. 28–35, 2005. View at Google Scholar · View at Scopus
  6. N. Carroll, J. Elliot, A. Morton, and A. James, “The structure of large and small airways in nonfatal and fatal asthma,” American Review of Respiratory Disease, vol. 147, no. 2, pp. 405–410, 1993. View at Google Scholar · View at Scopus
  7. A. L. James, P. D. Pare, and J. C. Hogg, “The mechanics of airway narrowing in asthma,” American Review of Respiratory Disease, vol. 139, no. 1, pp. 242–246, 1989. View at Google Scholar · View at Scopus
  8. M. Saetta, A. Di Stefano, C. Rosina, G. Thiene, and L. M. Fabbri, “Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma,” American Review of Respiratory Disease, vol. 143, no. 1, pp. 138–143, 1991. View at Google Scholar · View at Scopus
  9. J. A. Elias, Z. Zhu, G. Chupp, and R. J. Homer, “Airway remodeling in asthma,” Journal of Clinical Investigation, vol. 104, no. 8, pp. 1001–1005, 1999. View at Google Scholar · View at Scopus
  10. K. Kuwano, C. H. Bosken, P. D. Pare, T. R. Bai, B. R. Wiggs, and J. C. Hogg, “Small airways dimensions in asthma and in chronic obstructive pulmonary disease,” American Review of Respiratory Disease, vol. 148, no. 5, pp. 1220–1225, 1993. View at Google Scholar · View at Scopus
  11. A. J. James, “Relationship between airway wall thickness and airway hyperesponsiveness,” in Airway Wall Remodeling in Asthma, A. G. Stewart, Ed., pp. 1–27, CRC Press, Boca Raton, Fla, USA, 1997. View at Google Scholar
  12. N. Awadh, N. L. Müller, C. S. Park, R. T. Abboud, and J. M. FitzGerald, “Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning,” Thorax, vol. 53, no. 4, pp. 248–253, 1998. View at Google Scholar · View at Scopus
  13. S. A. Little, M. W. Sproule, M. D. Cowan et al., “High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity,” Thorax, vol. 57, no. 3, pp. 247–253, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Niimi, H. Matsumoto, R. Amitani et al., “Airway wall thickness in asthma assessed by computed tomography: relation to clinical indices,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 4, pp. 1518–1523, 2000. View at Google Scholar · View at Scopus
  15. T. Aikawa, S. Shimura, H. Sasaki, M. Ebina, and T. Takishima, “Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack,” Chest, vol. 101, no. 4, pp. 916–921, 1992. View at Google Scholar · View at Scopus
  16. X. Li and J. W. Wilson, “Increased vascularity of the bronchial mucosa in mild asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 156, no. 1, pp. 229–233, 1997. View at Google Scholar · View at Scopus
  17. W. R. Roche, J. H. Williams, R. Beasley, and S. T. Holgate, “Subepithelial fibrosis in the bronchi of asthmatics,” Lancet, vol. 1, no. 8637, pp. 520–524, 1989. View at Google Scholar · View at Scopus
  18. M. Castro, S. B. Fain, E. A. Hoffman, D. S. Gierada, S. C. Erzurum, and S. Wenzel, “Lung imaging in asthmatic patients: the picture is clearer,” Journal of Allergy and Clinical Immunology, vol. 128, no. 3, pp. 467–478, 2011. View at Publisher · View at Google Scholar · View at PubMed
  19. K. Kasahara, K. Shiba, T. Ozawa, K. Okuda, and M. Adachi, “Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma,” Thorax, vol. 57, no. 3, pp. 242–246, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. R. S. Aysola, E. A. Hoffman, D. Gierada et al., “Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology,” Chest, vol. 134, no. 6, pp. 1183–1191, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. R. M. Pascual and S. P. Peters, “Airway remodeling contributes to the progressive loss of lung function in asthma: an overview,” Journal of Allergy and Clinical Immunology, vol. 116, no. 3, pp. 477–486, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. S. T. Holgate, H. S. Arshad, G. C. Roberts, P. H. Howarth, P. Thurner, and D. E. Davies, “A new look at the pathogenesis of asthma,” Clinical Science, vol. 118, no. 7, pp. 439–450, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. L. Cohn, J. A. Elias, and G. L. Chupp, “Asthma: mechanisms of disease persistence and progression,” Annual Review of Immunology, vol. 22, pp. 789–815, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. Z. Zhu, R. J. Homer, Z. Wang et al., “Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production,” Journal of Clinical Investigation, vol. 103, no. 6, pp. 779–788, 1999. View at Google Scholar · View at Scopus
  25. J. J. Lee, M. P. McGarry, S. C. Farmer et al., “Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma,” Journal of Experimental Medicine, vol. 185, no. 12, pp. 2143–2156, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Jain-Vora, S. E. Wert, U. A. Temann, J. A. Rankin, and J. A. Whitsett, “Interleukin-4 alters epithelial cell differentiation and surfactant homeostasis in the postnatal mouse lung,” American Journal of Respiratory Cell and Molecular Biology, vol. 17, no. 5, pp. 541–551, 1997. View at Google Scholar · View at Scopus
  27. J. A. Rankin, D. E. Picarella, G. P. Geba et al., “Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 15, pp. 7821–7825, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Balzar, M. L. Fajt, S. A.A. Comhair et al., “Mast cell phenotype, location, and activation in severe asthma: data from the severe asthma research program,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 3, pp. 299–309, 2011. View at Publisher · View at Google Scholar · View at PubMed
  29. N. Pearce, J. Pekkanen, and R. Beasley, “How much asthma is really attributable to atopy?” Thorax, vol. 54, no. 3, pp. 268–272, 1999. View at Google Scholar · View at Scopus
  30. G. Turato, A. Barbato, S. Baraldo et al., “Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 5, pp. 476–482, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. The Lancet, “Asthma: still more questions than answers,” The Lancet, vol. 372, no. 9643, p. 1009, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. Y. Sumi and Q. Hamid, “Airway remodeling in asthma,” Allergology International, vol. 56, no. 4, pp. 341–348, 2007. View at Publisher · View at Google Scholar · View at PubMed
  33. S. T. Holgate, D. E. Davies, P. M. Lackie, S. J. Wilson, S. M. Puddicombe, and J. L. Lordan, “Epithelial-mesenchymal interactions in the pathogenesis of asthma,” Journal of Allergy and Clinical Immunology, vol. 105, no. 2, pp. 193–204, 2000. View at Google Scholar · View at Scopus
  34. S. T. Holgate, “Epithelium dysfunction in asthma,” Journal of Allergy and Clinical Immunology, vol. 120, no. 6, pp. 1233–1244, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. S. T. Holgate, J. Holloway, S. Wilson, F. Bucchieri, S. Puddicombe, and D. E. Davies, “Epithelial-mesenchymal communication in the pathogenesis of chronic asthma,” Proceedings of the American Thoracic Society, vol. 1, no. 2, pp. 93–98, 2004. View at Google Scholar
  36. A. C. Patel, J. D. Morton, E. Y. Kim et al., “Genetic segregation of airway disease traits despite redundancy of calcium-activated chloride channel family members,” Physiological Genomics, vol. 25, no. 3, pp. 502–513, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. J. W. Tyner, E. Y. Kim, K. Ide et al., “Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals,” Journal of Clinical Investigation, vol. 116, no. 2, pp. 309–321, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. M. H. Grayson, D. Cheung, M. M. Rohlfing et al., “Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia,” Journal of Experimental Medicine, vol. 204, no. 11, pp. 2759–2769, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. D. S. Cheung, S. J. Ehlenbach, R. T. Kitchens et al., “Cutting edge: CD49d+ neutrophils induce FcεRI expression on lung dendritic cells in a mouse model of postviral asthma,” Journal of Immunology, vol. 185, no. 9, pp. 4983–4987, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. M. J. Walter, J. D. Morton, N. Kajiwara, E. Agapov, and M. J. Holtzman, “Viral induction of a chronic asthma phenotype and genetic segregation from the acute response,” Journal of Clinical Investigation, vol. 110, no. 2, pp. 165–175, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Y. Kim, J. T. Battaile, A. C. Patel et al., “Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease,” Nature Medicine, vol. 14, no. 6, pp. 633–640, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. L. A. Benoit and M. J. Holtzman, “New immune pathways from chronic post-viral lung disease,” Annals of the New York Academy of Sciences, vol. 1183, pp. 195–210, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. M. J. Holtzman, D. A. Patel, Y. Zhang, and A. C. Patel, “Host epithelial-viral interactions as cause and cure for asthma,” Current Opinion in Immunology, vol. 23, no. 4, pp. 487–494, 2011. View at Publisher · View at Google Scholar · View at PubMed
  44. J. B. Domachowske and H. F. Rosenberg, “Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment,” Clinical Microbiology Reviews, vol. 12, no. 2, pp. 298–309, 1999. View at Google Scholar · View at Scopus
  45. R. Ahmed, L. A. Morrison, and D. M. Knipe, “Persistence of viruses,” in Fields Virology, B. N. Knipe, D. M. Knipe, and P. M. Howley, Eds., pp. 219–249, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 1996. View at Google Scholar
  46. N. Sigurs, “Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 3, pp. S2–S6, 2001. View at Google Scholar · View at Scopus
  47. B. NAYLOR, “The shedding of the mucosa of the bronchial tree in asthma,” Thorax, vol. 17, pp. 69–72, 1962. View at Google Scholar · View at Scopus
  48. L. A. Laitinen, M. Heino, and A. Laitinen, “Damage of the airway epithelium and bronchial reactivity in patients with asthma,” American Review of Respiratory Disease, vol. 131, no. 4, pp. 599–606, 1985. View at Google Scholar · View at Scopus
  49. L. Cohen, E. Xueping, J. Tarsi et al., “Epithelial cell proliferation contributes to airway remodeling in severe asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 2, pp. 138–145, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. C. Ordoñez, R. Ferrando, D. M. Hyde, H. H. Wong, and J. V. Fahy, “Epithelial desquamation in asthma: artifact or pathology?” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 6, pp. 2324–2329, 2000. View at Google Scholar · View at Scopus
  51. H. A. Jenkins, C. Cool, S. J. Szefler et al., “Histopathology of severe childhood asthma: a case series,” Chest, vol. 124, no. 1, pp. 32–41, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. C. L. Ordoñez, R. Khashayar, H. H. Wong et al., “Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 2, pp. 517–523, 2001. View at Google Scholar · View at Scopus
  53. E. Tagaya and J. Tamaoki, “Mechanisms of airway remodeling in asthma,” Allergology International, vol. 56, no. 4, pp. 331–340, 2007. View at Publisher · View at Google Scholar · View at PubMed
  54. J. V. Fahy, “Remodeling of the airway epithelium in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 10, pp. S46–51, 2001. View at Google Scholar · View at Scopus
  55. L. Cohn, J. S. Tepper, and K. Bottomly, “Cutting edge: IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells,” Journal of Immunology, vol. 161, no. 8, pp. 3813–3816, 1998. View at Google Scholar · View at Scopus
  56. D. A. Kuperman, X. Huang, L. L. Koth et al., “Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma,” Nature Medicine, vol. 8, no. 8, pp. 885–889, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. M. Amishima, M. Munakata, Y. Nasuhara et al., “Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 6, pp. 1907–1912, 1998. View at Google Scholar · View at Scopus
  58. S. M. Puddicombe, R. Polosa, A. Richter et al., “Involvement of the epidermal growth factor receptor in epithelial repair in asthma,” FASEB Journal, vol. 14, no. 10, pp. 1362–1374, 2000. View at Google Scholar
  59. K. Takeyama, J. V. Fahy, and J. A. Nadel, “Relationship of epidermal growth factor receptors to goblet cell production in human bronchi,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 2, pp. 511–516, 2001. View at Google Scholar · View at Scopus
  60. P. Demoly, J. Simony-Lafontaine, P. Chanez et al., “Cell proliferation in the bronchial mucosa of asthmatics and chronic bronchitics,” American Journal of Respiratory and Critical Care Medicine, vol. 150, no. 1, pp. 214–217, 1994. View at Google Scholar · View at Scopus
  61. H. L. Huber and K. K. Koessler, “The pathology of bronchial asthma,” Archives of Internal Medicine, vol. 30, no. 6, pp. 689–760, 1922. View at Google Scholar
  62. R. J. Homer and J. A. Elias, “Consequences of long-term inflammation: airway remodeling,” Clinics in Chest Medicine, vol. 21, no. 2, pp. 331–343, 2000. View at Google Scholar · View at Scopus
  63. J. Huang, R. Olivenstein, R. Taha, Q. Hamid, and M. Ludwig, “Enhanced proteoglycan deposition in the airway wall of atopic asthmatics,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 2, pp. 725–729, 1999. View at Google Scholar · View at Scopus
  64. A. Laitinen, A. Altraja, M. Kämpe, M. Linden, I. Virtanen, and L. A. Laitinen, “Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid,” American Journal of Respiratory and Critical Care Medicine, vol. 156, no. 3, pp. 951–958, 1997. View at Google Scholar · View at Scopus
  65. D. N. R. Payne, A. V. Rogers, E. Ädelroth et al., “Early thickening of the reticular basement membrane in children with difficult asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 1, pp. 78–82, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. L. P. Boulet, M. Laviolette, H. Turcotte et al., “Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine,” Chest, vol. 112, no. 1, pp. 45–52, 1997. View at Google Scholar · View at Scopus
  67. J. Chakir et al., “Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Laboratory investigation,” Laboratory Investigation, vol. 75, no. 5, pp. 735–744, 1996. View at Google Scholar
  68. H. W. Chu, J. L. Halliday, R. J. Martin, D. Y. M. Leung, S. J. Szefler, and S. E. Wenzel, “Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease,” American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 6, pp. 1936–1944, 1998. View at Google Scholar · View at Scopus
  69. S. E. Wenzel, L. B. Schwartz, E. L. Langmack et al., “Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 3, pp. 1001–1008, 1999. View at Google Scholar · View at Scopus
  70. L. Benayoun, A. Druilhe, M. C. Dombret, M. Aubier, and M. Pretolani, “Airway structural alterations selectively associated with severe asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 10, pp. 1360–1368, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. A. Chetta, A. Foresi, M. Del Donno, G. Bertorelli, A. Pesci, and D. Olivieri, “Airways remodeling is a distinctive feature of asthma and is related to severity of disease,” Chest, vol. 111, no. 4, pp. 852–857, 1997. View at Google Scholar · View at Scopus
  72. S. H. Cho, J. Y. Seo, D. C. Choi et al., “Pathological changes according to the severity of asthma,” Clinical and Experimental Allergy, vol. 26, no. 10, pp. 1210–1219, 1996. View at Publisher · View at Google Scholar
  73. Chun Geun Lee, R. J. Homer, Z. Zhu et al., “Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β1,” Journal of Experimental Medicine, vol. 194, no. 6, pp. 809–821, 2001. View at Publisher · View at Google Scholar · View at Scopus
  74. V. Batra, A. I. Musani, A. T. Hastie et al., “Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-β1, TGF-β2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on α-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts,” Clinical and Experimental Allergy, vol. 34, no. 3, pp. 437–444, 2004. View at Publisher · View at Google Scholar
  75. M. H. Branton and J. B. Kopp, “TGF-β and fibrosis,” Microbes and Infection, vol. 1, no. 15, pp. 1349–1365, 1999. View at Publisher · View at Google Scholar · View at Scopus
  76. E. M. Minshall, D. Y. M. Leung, R. J. Martin et al., “Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma,” American Journal of Respiratory Cell and Molecular Biology, vol. 17, no. 3, pp. 326–333, 1997. View at Google Scholar · View at Scopus
  77. I. Ohno, Y. Nitta, K. Yamauchi et al., “Transforming growth factor β1 (TGFβ1) gene expression by eosinophils in asthmatic airway inflammation,” American Journal of Respiratory Cell and Molecular Biology, vol. 15, no. 3, pp. 404–409, 1996. View at Google Scholar · View at Scopus
  78. L. P. Boulet, M. Belanger, and G. Carrier, “Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction,” American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 3, pp. 865–871, 1995. View at Google Scholar · View at Scopus
  79. R. Visse and H. Nagase, “Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry,” Circulation Research, vol. 92, no. 8, pp. 827–839, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. A. M. Vignola, L. Riccobono, A. Mirabella et al., “Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis,” American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 6, pp. 1945–1950, 1998. View at Google Scholar · View at Scopus
  81. M. Hoshino, Y. Nakamura, J. Sim, J. Shimojo, and S. Isogai, “Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation,” Journal of Allergy and Clinical Immunology, vol. 102, no. 5, pp. 783–788, 1998. View at Google Scholar · View at Scopus
  82. G. Mautino, C. Henriquet, C. Gougat et al., “Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma,” Laboratory Investigation, vol. 79, no. 1, pp. 39–47, 1999. View at Google Scholar
  83. E. A. Kelly and N. N. Jarjour, “Role of matrix metalloproteinases in asthma,” Current Opinion in Pulmonary Medicine, vol. 9, no. 1, pp. 28–33, 2003. View at Publisher · View at Google Scholar · View at Scopus
  84. M. Hyytiäinen, C. Penttinen, and J. Keski-Oja, “Latent TGF-β binding proteins: extracellular matrix association and roles in TGF-β activation,” Critical Reviews in Clinical Laboratory Sciences, vol. 41, no. 3, pp. 233–264, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  85. M. A. Swartz, D. J. Tschumperlin, R. D. Kamm, and J. M. Drazen, “Mechanical stress is communicated between different cell types to elicit matrix remodeling,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 11, pp. 6180–6185, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. A. T. Hastie, W. K. Kraft, K. B. Nyce et al., “Asthmatic epithelial cell proliferation and stimulation of collagen production: human asthmatic epithelial cells stimulate collagen type III production by human lung myofibroblasts after segmental allergen challenge,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 2, pp. 266–272, 2002. View at Google Scholar · View at Scopus
  87. A. E. Redington, J. Madden, A. J. Frew et al., “Transforming growth factor-β1 in asthma: measurement in bronchoalveolar lavage fluid,” American Journal of Respiratory and Critical Care Medicine, vol. 156, no. 2, pp. 642–647, 1997. View at Google Scholar · View at Scopus
  88. S. Beqaj, S. Jakkaraju, R. R. Mattingly, D. Pan, and L. Schuger, “High RhoA activity maintains the undifferentiated mesenchymal cell phenotype, whereas RhoA down-regulation by laminin-2 induces smooth muscle myogenesis,” Journal of Cell Biology, vol. 156, no. 5, pp. 893–903, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  89. S. J. Hirst, J. G. Martin, J. V. Bonacci et al., “Proliferative aspects of airway smooth muscle,” Journal of Allergy and Clinical Immunology, vol. 114, no. 2, pp. S2–S17, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. M. Schmidt, G. Sun, M. A. Stacey, L. Mori, and S. Mattoli, “Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma,” Journal of Immunology, vol. 171, no. 1, pp. 380–389, 2003. View at Google Scholar · View at Scopus
  91. C. Bergeron, W. Al-Ramli, and Q. Hamid, “Remodeling in asthma,” Proceedings of the American Thoracic Society, vol. 6, no. 3, pp. 301–305, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  92. S. Hossain, “Quantitative measurement of bronchial muscle in men with asthma,” American Review of Respiratory Disease, vol. 107, no. 1, pp. 99–109, 1973. View at Google Scholar · View at Scopus
  93. A. M. Freyer, S. R. Johnson, and I. P. Hall, “Effects of growth factors and extracellular matrix on survival of human airway smooth muscle cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 25, no. 5, pp. 569–576, 2001. View at Google Scholar · View at Scopus
  94. P. H. Howarth, A. J. Knox, Y. Amrani, O. Tliba, R. A. Panettieri, and M. Johnson, “Synthetic responses in airway smooth muscle,” Journal of Allergy and Clinical Immunology, vol. 114, no. 2, supplement 1, pp. S32–S50, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  95. K. Page, J. Li, Y. Wang, S. Kartha, R. G. Pestell, and M. B. Hershenson, “Regulation of cyclin D(1) expression and DNA synthesis by phosphatidylinositol 3-kinase in airway smooth muscle cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 23, no. 4, pp. 436–443, 2000. View at Google Scholar · View at Scopus
  96. M. J. Orsini, V. P. Krymskaya, A. J. Eszterhas, J. L. Benovic, R. A. Panettieri, and R. B. Penn, “MAPK superfamily activation in human airway smooth muscle: mitogenesis requires prolonged p42/p44 activation,” American Journal of Physiology, vol. 277, no. 3, pp. L479–L488, 1999. View at Google Scholar · View at Scopus
  97. J. M. Madison, “Migration of airway smooth muscle cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 29, no. 1, pp. 8–11, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  98. M. Hoshino, M. Takahashi, and N. Aoike, “Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis,” Journal of Allergy and Clinical Immunology, vol. 107, no. 2, pp. 295–301, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  99. H. Tanaka, G. Yamada, T. Saikai et al., “Increased Airway Vascularity in Newly Diagnosed Asthma Using a High-magnification Bronchovideoscope,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 12, pp. 1495–1499, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  100. G. Salvato, “Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects,” Thorax, vol. 56, no. 12, pp. 902–906, 2001. View at Publisher · View at Google Scholar · View at Scopus
  101. B. E. Orsida, C. Ward, X. Li et al., “Effect of a long-acting β2-agonist over three months on airway wall vascular remodeling in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 1, pp. 117–121, 2001. View at Google Scholar · View at Scopus
  102. B. E. Orsida, X. Li, B. Hickey, F. Thien, J. W. Wilson, and E. H. Walters, “Vascularity in asthmatic airways: relation to inhaled steroid dose,” Thorax, vol. 54, no. 4, pp. 289–295, 1999. View at Google Scholar · View at Scopus
  103. B. Vrugt, S. Wilson, A. Bron, S. T. Holgate, R. Djukanovic, and R. Aalbers, “Bronchial angiogenesis in severe glucocorticoid-dependent asthma,” European Respiratory Journal, vol. 15, no. 6, pp. 1014–1021, 2000. View at Publisher · View at Google Scholar
  104. G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak, “Vascular endothelial growth factor (VEGF) and its receptors,” FASEB Journal, vol. 13, no. 1, pp. 9–22, 1999. View at Google Scholar
  105. C. G. Lee, H. Link, P. Baluk et al., “Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung,” Nature Medicine, vol. 10, no. 10, pp. 1095–1103, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  106. J. Corne, G. Chupp, C. G. Lee et al., “IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury,” Journal of Clinical Investigation, vol. 106, no. 6, pp. 783–791, 2000. View at Google Scholar · View at Scopus
  107. M. Hoshino, Y. Nakamura, and Q. A. Hamid, “Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma,” Journal of Allergy and Clinical Immunology, vol. 107, no. 6, pp. 1034–1038, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  108. Yong Chul Lee and Hern Ku Lee, “Vascular endothelial growth factor in patients with acute asthma,” Journal of Allergy and Clinical Immunology, vol. 107, no. 6, p. 1106, 2001. View at Publisher · View at Google Scholar · View at Scopus
  109. T. R. Bai and D. A. Knight, “Structural changes in the airways in asthma: observations and consequences,” Clinical Science, vol. 108, no. 6, pp. 463–477, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  110. S. Siddiqui and J. G. Martin, “Structural aspects of airway remodeling in asthma,” Current Allergy and Asthma Reports, vol. 8, no. 6, pp. 540–547, 2008. View at Publisher · View at Google Scholar · View at Scopus
  111. R. K. Lambert, B. R. Wiggs, K. Kuwano, J. C. Hogg, and P. D. Pare, “Functional significance of increased airway smooth muscle in asthma and COPD,” Journal of Applied Physiology, vol. 74, no. 6, pp. 2771–2781, 1993. View at Google Scholar · View at Scopus
  112. M. Yanai, K. Sekizawa, T. Ohrui, H. Sasaki, and T. Takishima, “Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure,” Journal of Applied Physiology, vol. 72, no. 3, pp. 1016–1023, 1992. View at Google Scholar · View at Scopus
  113. E. M. Wagner, E. R. Bleecker, S. Permutt, and M. C. Liu, “Direct assessment of small airways reactivity in human subjects,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 2, pp. 447–452, 1998. View at Google Scholar · View at Scopus
  114. D. A. Kaminsky, S. E. Wenzel, C. Carcano, D. Gurka, D. Feldsien, and C. G. Irvin, “Hyperpnea-induced changes in parenchymal lung mechanics in normal subjects and in asthmatics,” American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 4, pp. 1260–1266, 1997. View at Google Scholar · View at Scopus
  115. T. Winkler and J. G. Venegas, “Complex airway behavior and paradoxical responses to bronchoprovocation,” Journal of Applied Physiology, vol. 103, no. 2, pp. 655–663, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  116. K. R. Lutchen and H. Gillis, “Relationship between heterogeneous changes in airway morphometry and lung resistance and elastance,” Journal of Applied Physiology, vol. 83, no. 4, pp. 1192–1201, 1997. View at Google Scholar · View at Scopus
  117. R. H. Brown, C. J. Herold, C. A. Hirshman, E. A. Zerhouni, and W. Mitzner, “Individual airway constrictor response heterogeneity to histamine assessed by high-resolution computed tomography,” Journal of Applied Physiology, vol. 74, no. 6, pp. 2615–2620, 1993. View at Google Scholar · View at Scopus
  118. R. H. Brown and W. Mitzner, “The myth of maximal airway responsiveness in vivo,” Journal of Applied Physiology, vol. 85, no. 6, pp. 2012–2017, 1998. View at Google Scholar · View at Scopus
  119. R. H. Brown, P. Croisille, B. Mudge, F. B. Diemer, S. Permutt, and A. Togias, “Airway narrowing in healthy humans inhaling methacholine without deep inspirations demonstrated by HRCT,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 4, pp. 1256–1263, 2000. View at Google Scholar · View at Scopus
  120. H. L. Gillis and K. R. Lutchen, “Airway remodeling in asthma amplifies heterogeneities in smooth muscle shortening causing hyperresponsiveness,” Journal of Applied Physiology, vol. 86, no. 6, pp. 2001–2012, 1999. View at Google Scholar · View at Scopus
  121. K. R. Lutchen, A. Jensen, H. Atileh et al., “Airway constriction pattern is a central component of asthma severity: the role of deep inspirations,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 2, pp. 207–215, 2001. View at Google Scholar · View at Scopus
  122. J. G. Martin, A. Duguet, and D. H. Eidelman, “The contribution of airway smooth muscle to airway narrowing and airway hyperresponsiveness in disease,” European Respiratory Journal, vol. 16, no. 2, pp. 349–354, 2000. View at Publisher · View at Google Scholar
  123. T. Bjorck, L. E. Gustafsson, and S. E. Dahlen, “Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine,” American Review of Respiratory Disease, vol. 145, no. 5, pp. 1087–1091, 1992. View at Google Scholar · View at Scopus
  124. R. W. Mitchell, E. Ruhlmann, H. Magnussen, A. R. Leff, and K. F. Rabe, “Passive sensitization of human bronchi augments smooth muscle shortening velocity and capacity,” American Journal of Physiology, vol. 267, no. 2, pp. L218–L222, 1994. View at Google Scholar · View at Scopus
  125. T. R. Bai, “Abnormalities in airway smooth muscle in fatal asthma: a comparison between trachea and bronchus,” American Review of Respiratory Disease, vol. 143, no. 2, pp. 441–443, 1991. View at Google Scholar · View at Scopus
  126. S. D. Whicker, C. L. Armour, and J. L. Black, “Responsiveness of bronchial smooth muscle from asthmatic patients to relaxant and contractile agonists,” Pulmonary Pharmacology, vol. 1, no. 1, pp. 25–31, 1988. View at Google Scholar · View at Scopus
  127. N. C. Thomson, “In vivo versus in vitro human airway responsiveness to different pharmacologic stimuli,” American Review of Respiratory Disease, vol. 136, no. 4, pp. S58–S62, 1987. View at Google Scholar · View at Scopus
  128. R. Léguillette and A. M. Lauzon, “Molecular mechanics of smooth muscle contractile proteins in airway hyperresponsiveness and asthma,” Proceedings of the American Thoracic Society, vol. 5, no. 1, pp. 40–46, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  129. R. Léguillette, M. Laviolette, C. Bergeron et al., “Myosin, transgelin, and myosin light chain kinase expression and function in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 3, pp. 194–204, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  130. X. Ma, Z. Cheng, H. Kong et al., “Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects,” American Journal of Physiology - Lung Cellular and Molecular Physiology, vol. 283, no. 6, pp. L1181–L1189, 2002. View at Google Scholar · View at Scopus
  131. A. Duguet, K. Biyah, E. Minshall et al., “Bronchial responsiveness among inbred mouse strains: role of airway smooth-muscle shortening velocity,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 3, pp. 839–848, 2000. View at Google Scholar · View at Scopus
  132. J. W. Wilson, X. Li, and M. C. F. Pain, “The lack of distensibility of asthmatic airways,” American Review of Respiratory Disease, vol. 148, no. 3, pp. 806–809, 1993. View at Google Scholar · View at Scopus
  133. H. J. L. Brackel, O. F. Pedersen, P. G. H. Mulder, S. E. Overbeek, K. F. Kerrebijn, and J. M. Bogaard, “Central airways behave more stiffly during forced expiration in patients with asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 3, pp. 896–904, 2000. View at Google Scholar · View at Scopus
  134. C. Ward, D. P. Johns, R. Bish et al., “Reduced airway distensibility, fixed airflow limitation, and airway wall remodeling in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 9, pp. 1718–1721, 2001. View at Google Scholar · View at Scopus
  135. S. Pitchford and C. Page, “Extracellular matrix composition influences the resistance of airway remodelling events towards glucocorticoid treatment,” British Journal of Pharmacology, vol. 138, no. 7, pp. 1181–1182, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  136. J. J. Fredberg, D. Inouye, B. Miller et al., “Airway smooth muscle, tidal stretches, and dynamically determined contractile states,” American Journal of Respiratory and Critical Care Medicine, vol. 156, no. 6, pp. 1752–1759, 1997. View at Google Scholar · View at Scopus
  137. S. J. Gunst and J. Q. Stropp, “Pressure-volume and length-stress relationships in canine bronchi in vitro,” Journal of Applied Physiology, vol. 64, no. 6, pp. 2522–2531, 1988. View at Google Scholar · View at Scopus
  138. T. R. Bai, J. H. T. Bates, V. Brusasco et al., “On the terminology for describing the length-force relationship and its changes in airway smooth muscle,” Journal of Applied Physiology, vol. 97, no. 6, pp. 2029–2034, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  139. B. E. McParland, P. T. Macklem, and P. D. Paré, “Airway wall remodeling: friend or foe?” Journal of Applied Physiology, vol. 95, no. 1, pp. 426–434, 2003. View at Google Scholar · View at Scopus
  140. A. Fust and N. L. Stephens, “Mechanical plasticity and contractile properties of airway smooth muscle,” Canadian Journal of Physiology and Pharmacology, vol. 83, no. 10, pp. 865–868, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  141. T. R. Bai, J. Cooper, T. Koelmeyer, P. D. Pare, and T. D. Weir, “The effect of age and duration of disease on airway structure in fatal asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 2, pp. 663–669, 2000. View at Google Scholar · View at Scopus
  142. N. J. Vanacker, E. Palmans, J. C. Kips, and R. A. Pauwels, “Fluticasone inhibits but does not reverse allergen-induced structural airway changes,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 3, pp. 674–679, 2001. View at Google Scholar · View at Scopus
  143. S. T. Holgate, “Novel targets of therapy in asthma,” Current Opinion in Pulmonary Medicine, vol. 15, no. 1, pp. 63–71, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  144. C. Ward, M. Pais, R. Bish et al., “Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma,” Thorax, vol. 57, no. 4, pp. 309–316, 2002. View at Publisher · View at Google Scholar · View at Scopus
  145. L. P. Boulet, H. Turcotte, M. Laviolette et al., “Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma: influence of inhaled corticosteroids,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 4, pp. 1308–1313, 2000. View at Google Scholar · View at Scopus
  146. J. Tonascia, N. F. Adkinson, B. Bender et al., “Long-term effects of budesonide or nedocromil in children with asthma,” New England Journal of Medicine, vol. 343, no. 15, pp. 1054–1063, 2000. View at Publisher · View at Google Scholar · View at PubMed
  147. H. H. Shen, S. I. Ochkur, M. P. McGarry et al., “A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse,” Journal of Immunology, vol. 170, no. 6, pp. 3296–3305, 2003. View at Google Scholar · View at Scopus
  148. C. Büttner, A. Lun, T. Splettstoesser, G. Kunkel, and H. Renz, “Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions,” European Respiratory Journal, vol. 21, no. 5, pp. 799–803, 2003. View at Publisher · View at Google Scholar
  149. P. T. Flood-Page, A. N. Menzies-Gow, A. B. Kay, and D. S. Robinson, “Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 2, pp. 199–204, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  150. J. C. Kips, B. J. O'Connor, S. J. Langley et al., “Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 12, pp. 1655–1659, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  151. M. J. Leckie, A. Ten Brinke, J. Khan et al., “Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response,” Lancet, vol. 356, pp. 2144–2148, 2000. View at Publisher · View at Google Scholar · View at Scopus
  152. P. Haldar, C. E. Brightling, B. Hargadon et al., “Mepolizumab and exacerbations of refractory eosinophilic asthma,” New England Journal of Medicine, vol. 360, no. 10, pp. 973–984, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  153. P. Nair, M. M. M. Pizzichini, M. Kjarsgaard et al., “Mepolizumab for prednisone-dependent asthma with sputum eosinophilia,” New England Journal of Medicine, vol. 360, no. 10, pp. 985–993, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  154. J. G. Ayres, B. Higgins, E. R. Chilvers, G. Ayre, M. Blogg, and H. Fox, “Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma,” Allergy, vol. 59, no. 7, pp. 701–708, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  155. S. T. Holgate, A. G. Chuchalin, J. Hébert et al., “Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma,” Clinical and Experimental Allergy, vol. 34, no. 4, pp. 632–638, 2004. View at Publisher · View at Google Scholar · View at PubMed
  156. R. Buhl, G. Hanf, M. Solèr et al., “The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma,” European Respiratory Journal, vol. 20, no. 5, pp. 1088–1094, 2002. View at Publisher · View at Google Scholar
  157. R. Buhl, M. Solèr, J. Matz et al., “Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma,” European Respiratory Journal, vol. 20, no. 1, pp. 73–78, 2002. View at Publisher · View at Google Scholar
  158. W. Busse, J. Corren, B. Q. Lanier et al., “Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma,” Journal of Allergy and Clinical Immunology, vol. 108, no. 2, pp. 184–190, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  159. M. Humbert, R. Beasley, J. Ayres et al., “Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE,” Allergy, vol. 60, no. 3, pp. 309–316, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  160. M. Diane Lougheed, C. Lemière, S. D. Dell et al., “Canadian thoracic society asthma management continuum—2010 consensus summary for children six years of age and over, and adults,” Canadian Respiratory Journal, vol. 17, no. 1, pp. 15–24, 2010. View at Google Scholar · View at Scopus
  161. P. P. Belliveau, “Omalizumab: a monoclonal anti-IgE antibody,” MedGenMed Medscape General Medicine, vol. 7, no. 1, p. 27, 2005. View at Google Scholar · View at Scopus
  162. R. Djukanović, S. J. Wilson, M. Kraft et al., “Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 170, no. 6, pp. 583–893, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  163. J. D. Miller, G. Cox, L. Vincic, C. M. Lombard, B. E. Loomas, and C. J. Danek, “A prospective feasibility study of bronchial thermoplasty in the human airway,” Chest, vol. 127, no. 6, pp. 1999–2006, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  164. M. Castro, A. S. Rubin, M. Laviolette et al., “Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial,” American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 2, pp. 116–124, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  165. G. Cox, N. C. Thomson, A. S. Rubin et al., “Asthma control during the year after bronchial thermoplasty,” New England Journal of Medicine, vol. 356, no. 13, pp. 1327–1337, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  166. N. C. Thomson, A. S. Rubin, R. M. Niven et al., “Long-term (5 year) safety of bronchial thermoplasty: asthma Intervention Research (AIR) trial,” BMC Pulmonary Medicine, vol. 11, no. 1, p. 8, 2011. View at Publisher · View at Google Scholar · View at PubMed
  167. G. Cox et al., “Long term safety of bronchial thermoplasty (BT): 3 year data from multiple studies,” American Journal of Respiratory and Critical Care Medicine, vol. 179, p. A2780, 2009. View at Google Scholar